Sector pending / Drugs, Drug Proprietaries, and Druggists' SundriesUpdated 2026-05-10 22:07 UTC

BCBA/CAH stock hub

BCBA/CAH has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BCBA/CAHis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

59.9T

Buenos Aires Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

BCBA/CAH

In the news

Latest news · BCBA/CAH

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E15.7

P25 n/aP50 n/aP75 n/a

Trailing P/E27.9

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROIC81

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BCBA/CAH market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

218

Groups with data

Currency

USD

Showing 218 of 218 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	AR
Employees	57,700
Employees Change	8,800%
Employees Change Percent	18
Enterprise value	ARS 67.1T
Exchange	Buenos Aires Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Drugs, Drug Proprietaries, and Druggists' Sundries
Last refreshed	2026-05-10
Market cap	ARS 59.9T
Price	ARS 91,500
Price currency	ARS
Rev Per Employee	6,253,499,378.42x
Sic	5122
Symbol	bcba/CAH
Website	https://www.cardinalhealth.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	3.59%
EV Earnings	31.22x
EV/EBIT	15.68x
EV/EBITDA	11.48x
EV/FCF	11.07x
EV/Sales	0.19x
FCF yield	10.11%
Forward P/E	15.73x
P/B ratio	-16.23x
P/E ratio	27.88x
P/S ratio	0.17x
PE Ratio10 Y	181.09x
PE Ratio3 Y	38.11x
PE Ratio5 Y	35.31x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	1.22%
EBITDA Margin	1.59%
FCF margin	1.75%
Gross margin	3.76%
Gross Profit	ARS 13T
Gross Profit Growth	19.98%
Gross Profit Growth Q	17.66%
Gross Profit Growth3 Y	12.2%
Gross Profit Growth5 Y	6.44%
Net Income	ARS 2.1T
Net Income Growth	-0.13%
Net Income Growth Q	-21.15%
Net Income Growth3 Y	49.76%
Net Income Growth5 Y	6.2%
Pretax Margin	0.8%
Profit Margin	0.62%
Profit Per Employee	ARS 38.8M
ROA	3.6
Roa5y	2.74
ROCE	20.88
ROIC	80.98

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	55.25%
Cagr3y	94.95%
Cagr5y	98.52%
Div CAGR10	111.92%
Div CAGR3	92.79%
Div CAGR5	87.34%
EPS Growth	2.48
EPS Growth Q	-19.52
EPS Growth3 Y	55.43
EPS Growth5 Y	10.85
FCF Growth	78.91%
FCF Growth Q	-39.98%
FCF Growth3 Y	-1.19%
FCF Growth5 Y	22.43%
OCF Growth	69.04%
OCF Growth Q	-37.57%
OCF Growth10 Y	4.57%
OCF Growth3 Y	0.19%
OCF Growth5 Y	20.07%
Revenue Growth	12.8x
Revenue Growth Q	11.05x
Revenue Growth3 Y	8.07x
Revenue Growth5 Y	9.88x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	ARS 4.71
Assets	ARS 78.3T
Cash	ARS 5.4T
Current Assets	ARS 53.2T
Current Liabilities	ARS 58.7T
Debt	ARS 12.3T
Debt EBITDA	ARS 2.13
Debt FCF	ARS 2.03
Equity	ARS -3.7T
Interest Coverage	10.73
Liabilities	ARS 82T
Long Term Assets	ARS 25.1T
Long Term Liabilities	ARS 23.3T
Net Cash	ARS -6.9T
Net Cash By Market Cap	ARS -11.48
Net Debt EBITDA	ARS 1.25
Net Debt FCF	ARS 1.14
Tangible Book Value	ARS -22.8T
Tangible Book Value Per Share	ARS -97,176

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.91
Inventory Turnover	14.13
Net Working Capital	ARS -9.9T
Quick ratio	0.42
Working Capital	ARS -5.4T
Working Capital Turnover	ARS -115,619

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	2.36%
Dividend Growth	36.71%
Dividend Growth Years	8%
Dividend per share	ARS 581
Dividend Years	27
Dividend Yield	0.63%
Ex Div Date	2026-04-01
Last Dividend	ARS 149
Payout Frequency	Quarterly
Payout Ratio	31.58%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	55.2%
200-day SMA	92,046.1
3Y total return	641.22%
50-day SMA	104,025.5
50-day SMA vs 200-day SMA	50over200
5Y total return	2,982.07%
All Time High	115,625
All Time High Change	-20.86%
All Time High Date	2026-02-06
All Time Low	2,426.5
All Time Low Change	3,670.86%
All Time Low Date	2021-02-18
ATR	2,699
Ch YTD	-13.23
High	94,200
High52	115,625
High52 Date	2026-02-06
High52ch	-20.86%
Low	91,200
Low52	56,350
Low52 Date	2025-05-12
Low52ch	62.38%
Ma50ch	-12.04%
Price vs 200-day SMA	-0.59%
RSI	31.42
RSI Monthly	64.32
RSI Weekly	42.73
Sharpe ratio	1.35x
Sortino ratio	2.33
Total Return	2.99%
Tr YTD	-12.9
Tr1m	-12.82%
Tr1w	-6.96%
Tr3m	-19.2%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	ARS 4.2T
Operating Income Growth	27.81
Operating Income Growth Q	17.78
Operating Income Growth3 Y	23.19
Operating Income Growth5 Y	10.33
Operating margin	1.22

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	233,745,620%
Net Borrowing	1,598,665,999,131
Shares Insiders	0.09%
Shares Institutions	90.64%
Shares Qo Q	-0.42%
Shares Yo Y	-2.36%
Short Ratio	3.24

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	ARS 5.4T
Average Volume	394.7x
Bv Per Share	-16,648.7
CAPEX	ARS -852.4B
Ch1m	-12.82
Ch1w	-6.96
Ch1y	54.04
Ch3m	-19.38
Ch3y	623.3
Ch5y	2,840.7
Ch6m	-8.06
Change	-0.35%
Change From Open	-2.01
Close	91,825
Days Gap	1.69
Depreciation Amortization	1,292,359,915,308
Dollar Volume	34,221,000
Earnings Date	2026-04-30
EBIT	ARS 4.2T
EBITDA	ARS 5.5T
EPS	ARS 9,031
F Score	6
FCF	ARS 6.1T
FCF EV Yield	9.03x
Financing CF	-620,299,651,300
Fiscal Year End	June
Founded	1,979
Goodwill	15,965,680,122,555
Income Tax	ARS 630B
Investing CF	-5,434,874,895,800
Is Primary Listing	0
Last Earnings Date	2026-04-30
Last Report Date	2026-03-31
Last Split Date	2001-04-23
Last Split Type	Forward
Lynch Fair Value	ARS 20,350
Lynch Upside	-77.76
Ma150	99,670.3
Ma150ch	-8.2%
Ma20	100,438.8
Ma20ch	-8.9%
Net CF	844,104,870,700
Next Earnings Date	2026-08-12
Open	93,375
P FCF Ratio	9.89
P OCF Ratio	8.67
Payment Date	2026-04-15
Position In Range	10
Ppne	4,095,270,380,976
Price Date	2026-05-08
Price EBITDA	ARS 10.86
Relative Volume	0.95x
Revenue	346,393,837,569,500x
SBC By Revenue	0.18x
Share Based Comp	638,259,329,400
Tax By Revenue	0.18x
Tax Rate	22.75%
Tr6m	-7.72%
Volume	374
Z Score	4.99

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

BCBA/CAH dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.6%

$581 annual per share

Payout ratio

+31.6%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+87.3%

8 consecutive years of growth

Total shareholder yield

+3.0%

Next ex-dividend date: 2026-04-01

Performance

BCBA/CAH stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BCBA/CAH?

Insider, institutional, and short-interest positioning.

Institutional ownership

+90.6%

Share of float held by funds and institutions

Insider ownership

+0.1%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

BCBA/CAH momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

31.4

Neutral momentum band

Price vs 200-day MA

-0.6%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

1.35

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BCBA/CAH

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bcba/CAH stock rating?

bcba/CAH is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bcba/CAH analysis?

The full report lives at /stocks/bcba/CAH/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bcba/CAH?

The latest report frames bcba/CAH around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bcba/CAH page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.